UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Representation of the cecum in the lateral dorsal motor nucleus of the vagus nerve and commissural subnucleus of the nucleus tractus solitarii in rat

Journal of comparative neurology (1911), 1991-02, Vol.304 (2), p.261-274

1991

Volltextzugriff (PDF)

Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management, 2nd edition

Gastrointestinal endoscopy, 1996-11, Vol.44 (5), p.641-641

Ferenci, David A.

1996

Volltextzugriff (PDF)

Management of Digestive and Liver Disorders in Infants and Children

Gastrointestinal endoscopy, 1995-03, Vol.41 (3), p.276-276

Ferenci, David A.

1995

Volltextzugriff (PDF)

J. Navarro J. Schmidt Paediatric Gastroenterology 1992 Oxford University Press 533 $150.00

Gastrointestinal Endoscopy, 1993, Vol.39 (4), p.608-608

Ferenci, David A.

1993

Volltextzugriff (PDF)

W.A. Walker P.R. Durie J.R. Hamilton J.A. Walker-Smith J.B. Watkins Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management Volumes I and II 1991 B. C. Decker, Inc. Philadelphia 1785 pp., $298.00

Gastrointestinal Endoscopy, 1991, Vol.37 (5), p.594-595

1991

Volltextzugriff (PDF)

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

Journal of hepatology, 2016-10, Vol.65 (4), p.692-699

2016

Volltextzugriff (PDF)

Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy

Hepatology (Baltimore, Md.), 2020-03, Vol.71 (3), p.1023-1036

2020

Volltextzugriff (PDF)

Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3

The New England journal of medicine, 2014-05, Vol.370 (21), p.1993-2001

2014

Volltextzugriff (PDF)

Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease

Hepatology (Baltimore, Md.), 2021-04, Vol.73 (4), p.1275-1289

2021

Volltextzugriff (PDF)

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

The New England journal of medicine, 2014-05, Vol.370 (21), p.1983-1992

2014

Volltextzugriff (PDF)

The ‘Viennese epidemic’ of acute HCV in the era of direct-acting antivirals

Journal of hepatology, 2022-07, Vol.77, p.S555

2022

Volltextzugriff (PDF)

The ‘Viennese epidemic’ of acute HCV in the era of direct‐acting antivirals

Journal of viral hepatitis, 2022-05, Vol.29 (5), p.385-394

2022

Volltextzugriff (PDF)

THU350 - Angiopoietin 2 levels decrease with SVR and correlate with dynamics of portal hypertension in patients with HCV-induced advanced chronic liver disease

Journal of hepatology, 2020-08, Vol.73, p.S311-S311

2020

Volltextzugriff (PDF)

Angiopoietin 2 levels decrease with SVR and correlate with dynamics of portal hypertension in patients with HCV-induced advanced chronic liver disease

Journal of hepatology, 2020-08, Vol.73, p.S311

2020

Volltextzugriff (PDF)

The alpha-1 antitrypsin PiZ allele is an independent risk factor for liver transplantation/death in patients with advanced chronic liver disease

Journal of hepatology, 2022-07, Vol.77, p.S535

2022

Volltextzugriff (PDF)

Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study

The lancet. Gastroenterology & hepatology, 2017-12, Vol.2 (12), p.869-876

2017

Volltextzugriff (PDF)

PROPEL: A randomized trial of mericitabine plus peginterferon alpha‐2a/ribavirin therapy in treatment‐naïve HCV genotype 1/4 patients

Hepatology (Baltimore, Md.), 2013-08, Vol.58 (2), p.524-537

2013

Volltextzugriff (PDF)

Progress of Hepatitis C elimination in Viennese people living with HIV after two decades of increasing cure rates

Infectious diseases (London, England), 2023-03, Vol.55 (3), p.189-198

2023

Volltextzugriff (PDF)

Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertension

Digestive and liver disease, 2022-09, Vol.54 (9), p.1222-1229

2022

Volltextzugriff (PDF)

Does Gender Have Prognostic Value Among Patients with Myocardial Infarction? Analysis of the Data from the Hungarian Myocardial Infarction Registry

Journal of women's health (Larchmont, N.Y. 2002), 2018-12, Vol.27 (12), p.1491

2018

Volltextzugriff (PDF)

Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease

JHEP reports, 2022-11, Vol.4 (11), p.100562-100562, Article 100562

2022

Volltextzugriff (PDF)

AS152 - Non-invasive monitoring of liver disease regression in patients with advanced chronic liver disease after sustained virologic response to INF-free therapies

Journal of hepatology, 2020-08, Vol.73, p.S105-S105

2020

Volltextzugriff (PDF)

Impact of genetic variants on liver disease regression in HCV patients with advanced chronic liver disease who achieved SVR to IFN-free therapies

Journal of hepatology, 2020-08, Vol.73, p.S608-S609

2020

Volltextzugriff (PDF)

FRI426 - Impact of genetic variants on liver disease regression in HCV patients with advanced chronic liver disease who achieved SVR to IFN-free therapies

Journal of hepatology, 2020-08, Vol.73, p.S608-S609

2020

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(47)
Reviews
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Representation of the cecum in the lateral dorsal motor nucleus of the vagus nerve and commissural subnucleus of the nucleus tractus solitarii in rat

Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management, 2nd edition

Management of Digestive and Liver Disorders in Infants and Children

J. Navarro J. Schmidt Paediatric Gastroenterology 1992 Oxford University Press 533 $150.00

W.A. Walker P.R. Durie J.R. Hamilton J.A. Walker-Smith J.B. Watkins Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management Volumes I and II 1991 B. C. Decker, Inc. Philadelphia 1785 pp., $298.00

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension

Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy

Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3

Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease

The ‘Viennese epidemic’ of acute HCV in the era of direct-acting antivirals

The ‘Viennese epidemic’ of acute HCV in the era of direct‐acting antivirals

THU350 - Angiopoietin 2 levels decrease with SVR and correlate with dynamics of portal hypertension in patients with HCV-induced advanced chronic liver disease

Angiopoietin 2 levels decrease with SVR and correlate with dynamics of portal hypertension in patients with HCV-induced advanced chronic liver disease

The alpha-1 antitrypsin PiZ allele is an independent risk factor for liver transplantation/death in patients with advanced chronic liver disease

Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study

PROPEL: A randomized trial of mericitabine plus peginterferon alpha‐2a/ribavirin therapy in treatment‐naïve HCV genotype 1/4 patients

Progress of Hepatitis C elimination in Viennese people living with HIV after two decades of increasing cure rates

Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertension

Does Gender Have Prognostic Value Among Patients with Myocardial Infarction? Analysis of the Data from the Hungarian Myocardial Infarction Registry

Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease

AS152 - Non-invasive monitoring of liver disease regression in patients with advanced chronic liver disease after sustained virologic response to INF-free therapies

Impact of genetic variants on liver disease regression in HCV patients with advanced chronic liver disease who achieved SVR to IFN-free therapies

FRI426 - Impact of genetic variants on liver disease regression in HCV patients with advanced chronic liver disease who achieved SVR to IFN-free therapies

Suchergebnisse filtern